CPT vs STOK · P/E 104, rev $5.3M vs rev $15.6M
Camden Property Trust (CPT) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. STOK currently screens at market cap $1.88B.
Not investment advice. Open the CPT and STOK stock pages for the full models.
Not investment advice.